| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |